Cerebrolysin (Ever Pharma)

Cerebrolysin is an injectable preparation containing a mixture of low-molecular-weight peptides and amino acids derived from porcine brain proteins. It is marketed in some countries for neurological conditions and is investigated for its potential neuroprotective and neurotrophic effects.

Potential Benefits:

• Investigated for cognitive and neurological recovery following stroke
• Studied for potential benefits in certain forms of dementia
• May support neurological rehabilitation in selected clinical settings
• Investigated for effects on neuronal function and recovery after brain injury
• Traumatic brain injury rehabilitation

• Cognitive impairment
• Other neurological recovery applications

Potential Side Effects:

• Headache or dizziness
• Nausea
• Sweating or agitation
• Injection-site reactions
• Rarely, allergic reactions